Management of Asthma in School age Children On Therapy - MASCOT

Keele University0 个研究点目标入组 450 人开始时间: 2008年4月18日最近更新: 2019年11月25日

适应症

试验速览

暂无简介。

•1.Children with physician diagnosed asthma aged 6 years -14 years, 11months
•2.Those requiring frequent short-acting beta2 agonist relief therapy = 7 puffs per week
•3.Those with symptoms of asthma (i.e. wheeze, shortness of breath but not cough alone) resulting in:
•i.Nocturnal wakening in the last week because of asthma symptoms and/or
•ii.Asthma has interfered with usual activities in the last week and/or
•iii.Those who have had exacerbations, defined as a short course of oral corticosteroids, an unscheduled GP or A&E Department visit or a hospital admission within the previous 6 months.
•4.Fully informed written (proxy) consent and assent, where appropriate
•Are the trial subjects under 18? yes
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) no
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•1.Children receiving long acting beta2-agonists, leukotriene receptor antagonists, regular theophylline therapy or high dose ICS (>1000micrograms and unlicensed beclometasone dipropionate or equivalent at the discretion of the investigator).
•2.Children with other respiratory diseases, cystic fibrosis, cardiac disease or immunological disorders.
•3.Non-English speaking

发起方